Short Communication

Early-Onset Somatic Delusional Presentation: A Case Report and Two-Decade Comparative Synthesis

Abstract

Objective: Somatic-type delusional disorder is characterized by fixed false beliefs related to bodily changes or illness. This report describes an unusual early-onset case associated with significant functional decline and compares its features with previously published cases.

Method: Clinical information was collected through psychiatric assessment, family interviews, physical and neurological examinations, laboratory investigations, and six months of follow-up. A narrative review of relevant English-language case reports published between 2003 and 2025 was also undertaken.

Results: A 22-year-old woman developed a persistent belief that self-inflicted cuts on her feet had permanently altered her joints and skin. Despite repeated reassurance and normal medical findings, she remained convinced of the perceived deformity. The condition was associated with depressed mood, social isolation, poor self-care, reduced food intake, and academic impairment. Investigations did not identify an underlying medical cause. Treatment with olanzapine, psychoeducation, supportive psychotherapy, and family counselling resulted in gradual improvement. During follow-up, delusional conviction decreased substantially, accompanied by better self-care, social interaction, and academic functioning. Review of the literature indicated that severe impairment and early onset are relatively uncommon in somatic-type delusional disorder.

Conclusion: Early-onset somatic delusions can lead to marked psychosocial dysfunction and may differ from the traditionally described pattern of preserved functioning. Comprehensive assessment, ongoing diagnostic review, and combined pharmacological and psychosocial interventions are important for achieving favorable outcomes.

1. Rustad JK, DeSimone AC, Goodman ZS, Ho PA, Schwartz R, Li DH, et al. Somatic Delusions: An Approach to Diagnosis and Treatment. Prim Care Companion CNS Disord. 2025;27(5).
2. Reilly TM. Monosymptomatic hypochondriacal Psychosis: Presentation and Treatment. Proc R Soc Med. 1977;70(Suppl 10):39-43.
3. Peralta V, Cuesta MJ. Delusional disorder and schizophrenia: a comparative study across multiple domains. Psychol Med. 2016;46(13):2829-39.
4. Hui CLM, Chan EWT, Hui PWM, Tao TJ, Ho ECN, Lam BST, et al. Functional and clinical outcomes of delusional disorder and schizophrenia patients after first episode psychosis: a 4-year follow-up study. BMC Psychiatry. 2023;23(1):676.
5. Mushtaq MA. The hidden struggle: Recognizing and treating delusional disorder. 2025.
6. Manschreck TC, Khan NL. Recent advances in the treatment of delusional disorder. Can J Psychiatry. 2006;51(2):114-9.
7. González-Rodríguez A, Monreal JA, Natividad M, Seeman MV. Seventy Years of Treating Delusional Disorder with Antipsychotics: A Historical Perspective. Biomedicines. 2022;10(12).
8. Jeste DV, Harris MJ, Krull A, Kuck J, McAdams LA, Heaton R. Clinical and neuropsychological characteristics of patients with late-onset schizophrenia. Am J Psychiatry. 1995;152(5):722-30.
9. Malla A, Norman R, Schmitz N, Manchanda R, Béchard-Evans L, Takhar J, et al. Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study. Psychol Med. 2006;36(5):649-58.
10. Crumlish N, Whitty P, Clarke M, Browne S, Kamali M, Gervin M, et al. Beyond the critical period: longitudinal study of 8-year outcome in first-episode non-affective psychosis. Br J Psychiatry. 2009;194(1):18-24.
11. Moola S, Munn Z, Sears K, Sfetcu R, Currie M, Lisy K, et al. Conducting systematic reviews of association (etiology): The Joanna Briggs Institute's approach. JBI Evidence Implementation. 2015;13(3):163-9.
12. Stephens JH, Richard P, McHugh PR. Long-term follow-up of patients with a diagnosis of paranoid state and hospitalized, 1913 to 1940. J Nerv Ment Dis. 2000;188(4):202-8.
13. AYDIN H, Yurdagül E. Monosymptomatic Hypochondriasis; A Case Report. TURKISH JOURNAL CLINICAL PSYCHIATRY.6(4):240-3.
14. Kepska A, Hawro T, Krupinska-Kun M, Zalewska A. Somatic-type delusional disorder: a case report and comments. Acta Derm Venereol. 2011;91(2):193-4.
15. Ajiboye PO, Yusuf AD. Monosymptomatic Hypochondriacal Psychosis (somatic delusional disorder): a report of two cases. Afr J Psychiatry (Johannesbg). 2013;16(2):87, 9.
16. Barone Y, Niolu C, Zanasi M, Siracusano A. Ekbom syndrome treated with olanzapine: a case report. Journal of Psychopathology. 2014;20:66-8.
17. Ranjan R, Nath S, Sethi G, Kumar P. A Hard Nut to Crack: Successful Resolution of Somatic Delusion with Electroconvulsive Therapy in a Case of Late Onset Persistent Delusional Disorder. Psychiatr Danub. 2021;33(4):566-8.
18. Vouk-Kamenski J, Vukojevic J, Celic I. Successful Treatment of Delusional Infestation with Olanzapine Depot. Alpha Psychiatry. 2021;22(6):324-7.0
19. Lochner C, Stein DJ. Olfactory reference syndrome: diagnostic criteria and differential diagnosis. J Postgrad Med. 2003;49(4):328-331.
20. Comardelle N, Edinoff A, Fort J. Delusions of Glass Under Skin: An Unusual Case of Somatic-Type Delusional Disorder Treated with Olanzapine. Health Psychol Res. 2022;10(3):35500.
Files
IssueArticles in Press QRcode
SectionShort Communication(s)
Keywords
Activities of Daily Living Age of Onset Cognitive Behavioral Therapy Delusions Diagnosis Differential Olanzapine Patient Education as Topic Psychotic Disorders

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
B LDB, Swetha Reddy A, B M M, Kumar Choudhary A. Early-Onset Somatic Delusional Presentation: A Case Report and Two-Decade Comparative Synthesis. Iran J Psychiatry. 2026;:1-13.